25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression

Table 2

Biochemical parameters.

Parameter	Patients	Control	significance; (patients versus control)
Lipids (g dL^−1)	618.7 ± 26.4	601.0 ± 37.1	0.741
Triglycerides (mg dL^−1)	89.9 ± 18.6	83.4 ± 16.6	0.449
Bilirubin (mg dL^−1)	0.22 ± 0.03	0.19 ± 0.08	0.811
Calcemia (mg dL^−1)	8.87 ± 0.30	8.76 ± 0.24	0.902
Calciuria (mg/24 h)	162.6 ± 31.4	153.9 ± 20.7	0.381
Alkaline phosphatase (U L^−1)	216.4 ± 31.5	209.7 ± 23.1	0.428
iPTH (pg mL^−1)	27.2 ± 7.4	31.0 ± 8.7	0.517
Phosphatemia (mg dL^−1)	3.6 ± 0.9	3.4 ± 0.6	0.726
CRP (mg dL^−1)	0.39 ± 0.23	0.13 ± 0.15	0.121
LDH (U L^−1)	396 ± 79	203 ± 62	0.014
IL-8 (pg mL^−1)	68.1 ± 16.3	10.2 ± 4.5	0.001
25(OH)D (ng mL^−1)	15.9 ± 11.8	26.8 ± 14.4	0.003

CRP: C reactive protein; iPTH: intact parathormone; LDH: lactate-dehydrogenase; IL-8: interleukin-8; and 25(OH)D3: 25-hydroxyvitamin D3.